{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:38:35Z","timestamp":1792589915519,"version":"4.5.0"},"reference-count":72,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Clin Rehabil"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To systematically evaluate the efficacy of hyperbaric oxygen therapy for non-motor symptoms in patients with Parkinson's disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data sources<\/jats:title>\n                    <jats:p>A systematic search was performed across several databases, including the Chinese Science and Technology Periodical Database, Web of Science, SinoMed, PubMed, Cochrane Library, Embase and Wanfang databases up to 1 December 2024. Studies considered for inclusion comprised randomised controlled trials and pre\u2013post control studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Review methods<\/jats:title>\n                    <jats:p>The authors conducted the data extraction and literature screening procedures independently. The selected studies\u2019 quality was evaluated using the Cochrane risk of bias technique. Review Manager 5.3 was used to conduct meta-analyses, while Stata 15.0 was utilised for sensitivity analysis and to assess publication bias.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Sixteen studies with a total of 1324 individuals satisfied the inclusion criteria. The results of the meta-analysis showed that hyperbaric oxygen therapy significantly improved scores on the Hamilton Anxiety Scale and Hamilton Depression Scale compared with baseline (both\n                      <jats:italic>p\u2009<\/jats:italic>\n                      &lt;\u20090.05). Additionally, improvements were observed in the Montreal Cognitive Assessment, Mini-Mental State Examination, Parkinson's Disease Sleep Scale, Pittsburgh Sleep Quality Index, Kubota's Drinking Water Test and Unified Parkinson's Disease Rating Scale III. Improvements in sleep efficiency and extension of total sleep time were also noted compared with controls (all\n                      <jats:italic>p\u2009<\/jats:italic>\n                      &lt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The findings indicate that hyperbaric oxygen therapy effectively alleviates non-motor symptoms such as anxiety, depression, cognitive impairments, sleep disturbances, and swallowing dysfunction, as well as improving motor function in Parkinson's disease patients. Since the hyperbaric oxygen therapy protocol had significant differences between studies, further prospective randomised controlled trials with rigorous methodology are needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/02692155241310750","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T04:07:30Z","timestamp":1736222850000},"page":"281-294","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Effect of hyperbaric oxygen therapy for non-motor symptoms among patients with Parkinson's disease: A systematic review and meta-analysis"],"prefix":"10.1177","volume":"39","author":[{"given":"Zhaoquan","family":"Pan","sequence":"first","affiliation":[{"name":"Guangxi University of Chinese Medicine, Guangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3009-0214","authenticated-orcid":false,"given":"Weiqiang","family":"Tan","sequence":"additional","affiliation":[{"name":"Guangxi University of Chinese Medicine, Guangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoke","family":"Ran","sequence":"additional","affiliation":[{"name":"Guangxi University of Chinese Medicine, Guangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyue","family":"Yan","sequence":"additional","affiliation":[{"name":"Guangzhou University of Chinese Medicine, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengxi","family":"Xie","sequence":"additional","affiliation":[{"name":"Maoming Hospital of Guangzhou University of Chinese Medicine, Maoming, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,1,7]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.13691"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2015.236"},{"key":"e_1_3_2_4_2","first-page":"302","article-title":"Nonmotor symptom complex of Parkinson\u2019s disease\u2014an underrecognized entity","volume":"59","author":"Mehndiratta M","year":"2011","unstructured":"Mehndiratta M, Garg RK, Pandey S. Nonmotor symptom complex of Parkinson\u2019s disease\u2014an underrecognized entity. J Assoc Physicians India 2011; 59: 302\u2013308.","journal-title":"J Assoc Physicians India"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/ijn.13177"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-009-5240-1"},{"key":"e_1_3_2_7_2","article-title":"Spectrum of non-motor symptoms in Parkinson\u2019s disease","volume":"13","author":"Kumaresan M","year":"2021","unstructured":"Kumaresan M, Khan S. Spectrum of non-motor symptoms in Parkinson\u2019s disease. Cureus 2021; 13: e13275.","journal-title":"Cureus"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1177\/2040622310387847"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23462"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.2174\/1871524920666200705222842"},{"key":"e_1_3_2_11_2","article-title":"Neuropathobiology of non-motor symptoms in Parkinson disease","volume":"122","author":"Jellinger KA","year":"2015","unstructured":"Jellinger KA. Neuropathobiology of non-motor symptoms in Parkinson disease. J Neural Transm-Gen 2015; 122: 1429\u20131440.","journal-title":"J Neural Transm-Gen"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2009.08.021"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.8940-21"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2007.08.015"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/bs.irn.2017.03.002"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1450134"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.1078544"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71"},{"key":"e_1_3_2_19_2","first-page":"000142","article-title":"Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions","volume":"10","author":"Cumpston M","year":"2019","unstructured":"Cumpston M, Li T, Page MJ, et al. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev 2019; 10: 000142.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.557"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.12"},{"key":"e_1_3_2_22_2","first-page":"176","article-title":"Effect of hyperbaric oxygen on the clinical symptoms of PD patients by interfering with cell senescence related\u2043phenotypes","volume":"30","author":"Zheng XQ","year":"2023","unstructured":"Zheng XQ, Zhu T, Cui HX, et al. Effect of hyperbaric oxygen on the clinical symptoms of PD patients by interfering with cell senescence related\u2043phenotypes. Chin J Naut Med Hyperbar Med 2023; 30: 176\u2013180.","journal-title":"Chin J Naut Med Hyperbar Med"},{"key":"e_1_3_2_23_2","first-page":"539","article-title":"Effects of hyperbaric oxygen therapy on emotion and cognitive disorders in patients with Parkinson\u2019s disease","volume":"27","author":"Qian H","year":"2020","unstructured":"Qian H, Zheng YB, Lin T, et al. Effects of hyperbaric oxygen therapy on emotion and cognitive disorders in patients with Parkinson\u2019s disease. Chin J Naut Med Hyperbar Med 2020; 27: 539\u2013542.","journal-title":"Chin J Naut Med Hyperbar Med"},{"key":"e_1_3_2_24_2","first-page":"116","article-title":"The effect of pramipexole dihydrochloride tablets combined with hyperbaric oxygen therapy on \u03b3-GABA and Glu in Parkinson patients with sleep disorders","volume":"19","author":"Zheng HH","year":"2022","unstructured":"Zheng HH, Bei N, Tang QF, et al. The effect of pramipexole dihydrochloride tablets combined with hyperbaric oxygen therapy on \u03b3-GABA and Glu in Parkinson patients with sleep disorders. J Hunan Normal Univ(Med Sci) 2022; 19: 116\u2013120.","journal-title":"J Hunan Normal Univ(Med Sci)"},{"key":"e_1_3_2_25_2","first-page":"109","article-title":"Effects of hyperbaric oxygen combined with Madopa and rehabilitation exercise on non-motor symptom and cognitive impairment in patients with Parkinson\u2019s disease","author":"Sun GZ","year":"2022","unstructured":"Sun GZ. Effects of hyperbaric oxygen combined with Madopa and rehabilitation exercise on non-motor symptom and cognitive impairment in patients with Parkinson\u2019s disease. Reflexol Rehabil Med 2022; 3: 109\u2013111.","journal-title":"Reflexol Rehabil Med"},{"key":"e_1_3_2_26_2","first-page":"96","article-title":"The effect of pramipexole combined with hyperbaric oxygen chamber on total sleep time and awakening times in patients with Parkinson\u2019s disease complicated with sleep disorders","volume":"27","author":"Luan H","year":"2021","unstructured":"Luan H, Fu YD. The effect of pramipexole combined with hyperbaric oxygen chamber on total sleep time and awakening times in patients with Parkinson\u2019s disease complicated with sleep disorders. Contemp Med 2021; 27: 96\u201398.","journal-title":"Contemp Med"},{"key":"e_1_3_2_27_2","first-page":"158","article-title":"The effect of hyperbaric oxygen therapy on non motor symptoms and oxidative stress in patients with primary Parkinson\u2019s disease","volume":"14","author":"Wang LJ","year":"2021","unstructured":"Wang LJ, Feng XF, Du XH, et al. The effect of hyperbaric oxygen therapy on non motor symptoms and oxidative stress in patients with primary Parkinson\u2019s disease. Chin J Clin Ration Drug Use 2021; 14: 158\u2013160.","journal-title":"Chin J Clin Ration Drug Use"},{"key":"e_1_3_2_28_2","first-page":"146","article-title":"Observation on the therapeutic effect of hyperbaric oxygen therapy on dementia patients with Parkinson\u2019s disease","volume":"37","author":"Peng W","year":"2021","unstructured":"Peng W, Song H, Wang FQ, et al. Observation on the therapeutic effect of hyperbaric oxygen therapy on dementia patients with Parkinson\u2019s disease. Gansu Sci Technol 2021; 37: 146\u2013148.","journal-title":"Gansu Sci Technol"},{"key":"e_1_3_2_29_2","first-page":"200","article-title":"Effects of hyperbaric oxygen combined with selegiline on motor function, serum miR-124, and IGF-1 in patients with Parkinson\u2019s disease","volume":"27","author":"Chen YM","year":"2020","unstructured":"Chen YM, Zhang X, Feng QY, et al. Effects of hyperbaric oxygen combined with selegiline on motor function, serum miR-124, and IGF-1 in patients with Parkinson\u2019s disease. Chin J Naut Med Hyperbar Med 2020; 27: 200\u2013204.","journal-title":"Chin J Naut Med Hyperbar Med"},{"key":"e_1_3_2_30_2","first-page":"37","article-title":"Effect of hyperbaric oxygen combined with memantine hydrochloride in the treatment of dementia patients with Parkinson\u2019s disease","volume":"27","author":"Peng W","year":"2020","unstructured":"Peng W, Hai S, Wang YM, et al. Effect of hyperbaric oxygen combined with memantine hydrochloride in the treatment of dementia patients with Parkinson\u2019s disease. China Mod Med 2020; 27: 37\u20133955.","journal-title":"China Mod Med"},{"key":"e_1_3_2_31_2","first-page":"254","article-title":"Clinical efficacy of hyperbaric oxygen assisted therapy in patients with Parkinson\u2019s disease and mild cognitive impairment","volume":"26","author":"Cheng JQ","year":"2019","unstructured":"Cheng JQ, Liu Y, Wu S, et al. Clinical efficacy of hyperbaric oxygen assisted therapy in patients with Parkinson\u2019s disease and mild cognitive impairment. Chin J Naut Med Hyperbar Med 2019; 26: 254\u2013256.","journal-title":"Chin J Naut Med Hyperbar Med"},{"key":"e_1_3_2_32_2","first-page":"22+37","article-title":"Observation on the application effect of pramipexole combined with hyperbaric oxygen chamber in the treatment of Parkinson\u2019s disease patients with sleep disorders","volume":"5","author":"Li HL","year":"2018","unstructured":"Li HL. Observation on the application effect of pramipexole combined with hyperbaric oxygen chamber in the treatment of Parkinson\u2019s disease patients with sleep disorders. J Clin Med 2018; 5: 22+37.","journal-title":"J Clin Med"},{"key":"e_1_3_2_33_2","first-page":"78","article-title":"Curative effect of pramipexole combined with hyperbaric oxygen chamber in the treatment of Parkinson disease combined with dyssomnia","volume":"15","author":"Liu YY","year":"2018","unstructured":"Liu YY, Gao XB ML, et al. Curative effect of pramipexole combined with hyperbaric oxygen chamber in the treatment of Parkinson disease combined with dyssomnia. Guiding J Trad Chin Med Pharm 2018; 15: 78\u201381+90.","journal-title":"Guiding J Trad Chin Med Pharm"},{"key":"e_1_3_2_34_2","first-page":"173","article-title":"Observation on the therapeutic effect of hyperbaric oxygenation on swallowing dysfunction of patients with Parkinson\u2019s disease","volume":"24","author":"Sun LJ","year":"2017","unstructured":"Sun LJ. Observation on the therapeutic effect of hyperbaric oxygenation on swallowing dysfunction of patients with Parkinson\u2019s disease. Clin Med Eng 2017; 24: 173\u2013175.","journal-title":"Clin Med Eng"},{"key":"e_1_3_2_35_2","first-page":"186","article-title":"Curative effect observation of pramipexole in combination with hyperbaric oxygen therapy in Parkinson\u2019s disease patients with dyssomnia","volume":"23","author":"Wang GJ","year":"2017","unstructured":"Wang GJ. Curative effect observation of pramipexole in combination with hyperbaric oxygen therapy in Parkinson\u2019s disease patients with dyssomnia. Int Med Health Guidance News 2017; 23: 186\u2013189.","journal-title":"Int Med Health Guidance News"},{"key":"e_1_3_2_36_2","first-page":"125","article-title":"Curative effect of pramipexole in combination with hyperbaric oxygen therapy in Parkinson\u2019s disease patients with dyssomnia","volume":"18","author":"Pan Y","year":"2016","unstructured":"Pan Y. Curative effect of pramipexole in combination with hyperbaric oxygen therapy in Parkinson\u2019s disease patients with dyssomnia. Chin J Geriatr Heart Brain Vessel Dis 2016; 18: 125\u2013128.","journal-title":"Chin J Geriatr Heart Brain Vessel Dis"},{"key":"e_1_3_2_37_2","first-page":"50","article-title":"Clinical effect of pramipexole combined with hyperbaric oxygen in the treatment of patients combined with Parkinson\u2019s disease and sleep disorder","volume":"13","author":"Liu YX","year":"2016","unstructured":"Liu YX. Clinical effect of pramipexole combined with hyperbaric oxygen in the treatment of patients combined with Parkinson\u2019s disease and sleep disorder. Guiding J Trad Chin Med Pharm 2016; 13: 50\u201353.","journal-title":"Guiding J Trad Chin Med Pharm"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2022.104749"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26643"},{"key":"e_1_3_2_40_2","article-title":"Hyperbaric oxygen treatment for Parkinson\u2019s disease with severe depression and anxiety: A case report","volume":"97","author":"Xu JJ","year":"2018","unstructured":"Xu JJ, Yang ST, Sha Y, et al. Hyperbaric oxygen treatment for Parkinson\u2019s disease with severe depression and anxiety: A case report. Medicine 2018; 97: e0029.","journal-title":"Medicine"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2020.105910"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.33667\/2078-5631-2022-3-47-49"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2020.02.004"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2016.12.118"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2011.11.010"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20527"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2019.00086"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.3390\/biom11101520"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-201074"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.23925"},{"key":"e_1_3_2_51_2","first-page":"219056","article-title":"Sleep disturbances associated with Parkinson's disease","volume":"2011","author":"Suzuki K","year":"2011","unstructured":"Suzuki K, Miyamoto M, Miyamoto T, et al. Sleep disturbances associated with Parkinson's disease. Parkinsons Dis 2011; 2011: 219056.","journal-title":"Parkinsons Dis"},{"key":"e_1_3_2_52_2","first-page":"377","article-title":"Application of polysomnographic surveillance in the diagnosis of sleep disorders associated with 352 Parkinson's disease","volume":"17","author":"Liu CF","year":"2018","unstructured":"Liu CF, Xu X, Shen Y. Application of polysomnographic surveillance in the diagnosis of sleep disorders associated with 352 Parkinson's disease. J Diagn Concep Pract 2018; 17: 377\u2013381.","journal-title":"J Diagn Concep Pract"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2018.06.006"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1111\/pcn.12478"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2011.11.006"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0197608"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1017\/cjn.2015.49"},{"key":"e_1_3_2_58_2","first-page":"255","article-title":"Observation on the therapeutic effect of hyperbaric oxygen comprehensive treatment for Parkinson\u2019s disease","author":"Yang LL","year":"2006","unstructured":"Yang LL, Li ZG, Gao HC. Observation on the therapeutic effect of hyperbaric oxygen comprehensive treatment for Parkinson\u2019s disease. Chin J Naut Med Hyperbar Med 2006; 4: 255\u2013256.","journal-title":"Chin J Naut Med Hyperbar Med"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.3390\/cells8070712"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2018.09.003"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(03)00244-6"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2007.01.010"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.3390\/biom10091247"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1111\/cns.13124"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.853372"},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.593026"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nrl.2013.02.014"},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.749026"},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.2174\/1567202610666131124234506"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002151"},{"key":"e_1_3_2_71_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122358"},{"key":"e_1_3_2_72_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.884506"},{"key":"e_1_3_2_73_2","doi-asserted-by":"publisher","DOI":"10.2174\/1871527322666230330093829"}],"container-title":["Clinical Rehabilitation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02692155241310750","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/02692155241310750","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02692155241310750","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:50:48Z","timestamp":1777395048000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/02692155241310750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,7]]},"references-count":72,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["10.1177\/02692155241310750"],"URL":"https:\/\/doi.org\/10.1177\/02692155241310750","relation":{},"ISSN":["0269-2155","1477-0873"],"issn-type":[{"value":"0269-2155","type":"print"},{"value":"1477-0873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,7]]}}}